亚宝药业 (600351)

Yabao Pharmaceutical Group Co., Ltd.

ASH

Tags

Traditional Chinese MedicineCSI Share Buyback IndexInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareBuyback PlansInfant and Child ConceptHelicobacter PyloriVitaminsFree Cash FlowMargin Trading and Securities LendingHigh-Dividend Yield Stocks医药生物中药Ⅱ

K-Line Chart

No K-line data available

Company Name亚宝药业集团股份有限公司
Listing Date2002-09-26
Issue Price4.8RMB
Registered Capital69200.004610k RMB
Legal Representative任武贤
Registered Address山西省芮城县富民路43号
Industry中药Ⅱ
Main Business 中西药制剂、化学合成原料药的生产与销售。
Company Profile 亚宝药业集团股份有限公司是山西省医药行业首家上市公司和首批认定的高新技术企业。集研发、生产、销售和中药材种植于一体,下设21个分子公司,资产总额42.5亿元,年销售收入20多亿元,员工5600余人。 在全国5030余家医药企业中,亚宝药业综合实力排名第87名,是工信部认定的“中国医药工业百强企业”,创新力居全国20强之列 ,是 “中国医药研发产品线最佳工业企业” 。“亚宝”商标为中国驰名商标。

Stock Details

1. Key Indicators

  • Total Shares(W): 70000.00
  • Circulating A-Shares(W): 70000.00
  • Earnings Per Share(RMB): 0.3066
  • Net Assets Per Share(RMB): 3.9939
  • Operating Revenue(W RMB): 170871.22
  • Total Profit(W RMB): 25336.40
  • **Net Profit Attributable to Parent(W RMB) **: 21509.43
  • Net Profit Growth Rate(%): -8.44
  • Weighted Return on Equity(%): 7.5200
  • Operating Cash Flow Per Share(RMB): 0.6520
  • Undistributed Profit Per Share(RMB): 1.7957
  • Capital Reserve Per Share(RMB): 0.8494

2. Main Business

The main business covers:

  • Production and sales of Chinese and Western medicine preparations
  • Production and sales of chemical synthetic bulk drugs

3. Company Basic Information

  • Company Name: Yabao Pharmaceutical Group Co., Ltd.
  • Listing Date: 2002-09-26
  • Industry: Pharmaceutical Manufacturing
  • Address: Floor 11, Building 2, No. 11 Yard, Tianhua North Street, Beijing Economic-Technological Development Area
  • Website: https://www.yabao.com.cn
  • Company Profile: Approved by the relevant laws and regulations including the "Company Law of the People's Republic of China," and authorized by the Shanxi Provincial People's Government Document Jin Zheng Han (1998) No. 172 "Reply on Approving the Establishment of Shanxi Yabao Pharmaceutical Group Co., Ltd.", the company was established on January 26, 1999. It was initiated by Shanxi Ruicheng Pharmaceutical Factory as the main sponsor, jointly with four other legal entities: Shanxi Provincial Economic Construction Investment Company, Shanxi Provincial Science and Technology Fund Development General Company, Datong Traditional Chinese Medicine Factory, and Shanxi Provincial Economic and Trade Assets Management Co., Ltd.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shanxi Yabao Investment Group Co., Ltd. General Legal Person 9430.00 13.47
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 3074.63 4.39
3 Datong Traditional Chinese Medicine Factory General Legal Person 622.00 0.89
4 Industrial Securities Asset Management - Huayuan Land Port Capital Operation Co., Ltd. - Industrial Securities Asset Management Alpha Kerui No. 106 Single Asset Management Plan Asset Management Plan 475.00 0.68
5 ChinaAMC SSE Traditional Chinese Medicine ETF Fund 436.21 0.62
6 Longkou Jiayuan Wolfman Auto Parts Co., Ltd. General Legal Person 406.26 0.58

5. Concept Sectors

  • Baby & Child Concept
  • Vitamins
  • Helicobacter Pylori
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High Dividend Stocks
  • Share Buyback Plan
  • Free Cash Flow
  • CSI Share Buybacks

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information